The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 04, 2017

Filed:

Nov. 22, 2011
Applicant:

Jens Sommer-knudsen, Gordon, AU;

Inventor:

Jens Sommer-Knudsen, Gordon, AU;

Assignee:

ELASTAGEN PTY. LIMITED, Eveleigh, New South Wales, AU;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/64 (2006.01); A61Q 19/08 (2006.01); A61L 27/22 (2006.01); C07K 14/78 (2006.01); A61L 27/20 (2006.01); A61L 27/26 (2006.01); C08B 11/08 (2006.01); C08B 11/12 (2006.01); C08B 33/04 (2006.01); C08B 37/00 (2006.01); C08B 37/02 (2006.01); C08B 37/08 (2006.01); C08H 1/00 (2006.01); C08H 1/06 (2006.01); C08L 1/28 (2006.01); C08L 3/14 (2006.01); C08L 5/00 (2006.01); C08L 5/02 (2006.01); C08L 5/04 (2006.01); C08L 5/08 (2006.01); C08L 5/10 (2006.01); C08L 89/00 (2006.01); C08L 89/06 (2006.01);
U.S. Cl.
CPC ...
C07K 14/78 (2013.01); A61K 8/64 (2013.01); A61L 27/20 (2013.01); A61L 27/22 (2013.01); A61L 27/26 (2013.01); A61Q 19/08 (2013.01); C08B 11/08 (2013.01); C08B 11/12 (2013.01); C08B 33/04 (2013.01); C08B 37/0009 (2013.01); C08B 37/0021 (2013.01); C08B 37/0024 (2013.01); C08B 37/0033 (2013.01); C08B 37/0063 (2013.01); C08B 37/0069 (2013.01); C08B 37/0072 (2013.01); C08B 37/0075 (2013.01); C08B 37/0084 (2013.01); C08B 37/0096 (2013.01); C08H 1/00 (2013.01); C08H 1/06 (2013.01); C08L 1/28 (2013.01); C08L 1/284 (2013.01); C08L 1/286 (2013.01); C08L 3/14 (2013.01); C08L 5/00 (2013.01); C08L 5/02 (2013.01); C08L 5/04 (2013.01); C08L 5/08 (2013.01); C08L 5/10 (2013.01); C08L 89/00 (2013.01); C08L 89/06 (2013.01); A61K 2800/91 (2013.01); A61L 2400/06 (2013.01); A61L 2430/34 (2013.01);
Abstract

Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative. The therapeutic compositions may be administered topically or by injection. The present disclosure also provides methods, systems, and/or kits for the preparation and/or formulation of the compositions disclosed herein.


Find Patent Forward Citations

Loading…